Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.
Luo Z, Huang Y, Batra N, Chen Y, Huang H, Wang Y, Zhang Z, Li S, Chen CY, Wang Z, Sun J, Wang QJ, Yang D, Lu B, Conway JF, Li LY, Yu AM, Li S.
Luo Z, et al. Among authors: huang h, huang y.
Nat Commun. 2024 Jan 4;15(1):255. doi: 10.1038/s41467-023-44572-6.
Nat Commun. 2024.
PMID: 38177179
Free PMC article.